Zhisong He

Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials

Xinan Sheng, Lin Wang, Zhisong He et al. · Journal of Clinical Oncology · 2023 · 125 citations · Full text

Single-cell transcriptomics reveals a low CD8⁺ T cell infiltrating state mediated by fibroblasts in recurrent renal cell carcinoma

Yulu Peng, Longbin Xiong, Zhaohui Zhou et al. · Journal for ImmunoTherapy of Cancer · 2022 · 68 citations · Full text

A phase II study of RC48-ADC in HER2-positive patients with locally advanced or metastatic urothelial carcinoma.

Xinan Sheng, Ai-Ping Zhou, Xin Yao et al. · Journal of Clinical Oncology · 2019 · 39 citations

Rc48-adc Treatment, Urology, Metastatic Urothelial Carcinoma +13

RC48-ADC for metastatic urothelial carcinoma with HER2-positive: Combined analysis of RC48-C005 and RC48-C009 trials.

Xinan Sheng, Zhisong He, Yanxia Shi et al. · Journal of Clinical Oncology · 2022 · 33 citations

Immunology, Visceral Metastases, Pharmacotherapy +22

UPK3A: A Promising Novel Urinary Marker for the Detection of Bladder Cancer

Yongqing Lai, Jiongxian Ye, Jing Chen et al. · Urology · 2010 · 31 citations

Urological Research, Urology, Genitourinary Cancer +7